![Patent Term Extension and the Active Ingredient Problem - NYU Journal of Intellectual Property & Entertainment Law Patent Term Extension and the Active Ingredient Problem - NYU Journal of Intellectual Property & Entertainment Law](https://jipel.law.nyu.edu/wp-content/uploads/2020/05/image001-1.png)
Patent Term Extension and the Active Ingredient Problem - NYU Journal of Intellectual Property & Entertainment Law
![New Ruling on Scope of Protection of Extended Patent Rights in JAPAN – Japanese Patent Attorneys | Allegro IP New Ruling on Scope of Protection of Extended Patent Rights in JAPAN – Japanese Patent Attorneys | Allegro IP](https://allegropat.com/wp-content/uploads/2019/05/US-and-JP-practices.jpg)
New Ruling on Scope of Protection of Extended Patent Rights in JAPAN – Japanese Patent Attorneys | Allegro IP
![Patent Term Extension for Drugs not Limited to new Chemical Entities – DrugPatentWatch - Make Better Decisions Patent Term Extension for Drugs not Limited to new Chemical Entities – DrugPatentWatch - Make Better Decisions](https://i0.wp.com/www.drugpatentwatch.com/blog/wp-content/uploads/2017/10/drug-patent-term-extension.jpg?fit=500%2C350&ssl=1)
Patent Term Extension for Drugs not Limited to new Chemical Entities – DrugPatentWatch - Make Better Decisions
![Federal Circuit Finds that “Effective” Extension of Term for Additional Patent is a “Permissible Consequence” of Patent Term Extension Provisions of 35 U.S.C. §156 - SGR Law Federal Circuit Finds that “Effective” Extension of Term for Additional Patent is a “Permissible Consequence” of Patent Term Extension Provisions of 35 U.S.C. §156 - SGR Law](https://www.sgrlaw.com/wp-content/uploads/2018/12/PTEArticle-300x163.png)
Federal Circuit Finds that “Effective” Extension of Term for Additional Patent is a “Permissible Consequence” of Patent Term Extension Provisions of 35 U.S.C. §156 - SGR Law
![Patent term extension in Japan: challenges still lay ahead even after the 2011 revision | Pharmaceutical Patent Analyst Patent term extension in Japan: challenges still lay ahead even after the 2011 revision | Pharmaceutical Patent Analyst](https://www.future-science.com/cms/10.4155/ppa.12.80/asset/images/medium/figure2.gif)
Patent term extension in Japan: challenges still lay ahead even after the 2011 revision | Pharmaceutical Patent Analyst
![Part 1 of 3: Patent Term Extension laws for Europe and the United States of America: compared and contrasted Part 1 of 3: Patent Term Extension laws for Europe and the United States of America: compared and contrasted](https://iiprd.files.wordpress.com/2015/05/blog1-2.png)
Part 1 of 3: Patent Term Extension laws for Europe and the United States of America: compared and contrasted
![Patent term extension in Japan: challenges still lay ahead even after the 2011 revision | Pharmaceutical Patent Analyst Patent term extension in Japan: challenges still lay ahead even after the 2011 revision | Pharmaceutical Patent Analyst](https://www.future-science.com/cms/10.4155/ppa.12.80/asset/images/medium/figure1.gif)
Patent term extension in Japan: challenges still lay ahead even after the 2011 revision | Pharmaceutical Patent Analyst
![Patent Owners Win as Federal Circuit Reins in Gilead and AbbVie Double Patenting Rulings | Fenwick & West LLP - JDSupra Patent Owners Win as Federal Circuit Reins in Gilead and AbbVie Double Patenting Rulings | Fenwick & West LLP - JDSupra](https://jdsupra-html-images.s3-us-west-1.amazonaws.com/392cc21a-e60e-44df-a2dc-7a9ab18c1ac0-Novartis-v-Breckenridge-pg-7.gif)